Relapsed actinic keratosis evaluation

An observational Italian multicenter prospective study. Does gender have a role?

S. Javor, S. Chimenti, A. Patrizi, L. Stingeni, G. Pellacani, S. Cavicchini, R. Sala, F. Rongioletti, A. Parodi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim. Relapsed actinic keratoses evaluation study (RAKE) was performed in nine Italian centers of dermatology in order to observe the outcome of the treatments of these common skin neoplasms. Methods. A total of 182 patients were enrolled in 2 cohorts: the first included 144/182 patients (79.1%) evaluated after 6 months from clinical remission, and the second 116/182 (63.7%) evaluated for at least 12 months after clinical remission. Patients were previously treated with topical diclofenac 3% in hyaluronic acid, cryotherapy, photodynamic, curettage or imiquimod cream. Results. Subjects with history of malignant skin diseases showed an increased number of new lesions at 16 months from baseline (12 months from remission) compared to patients without history of cancers (mean 1.58 versus 1.17). Hyperkeratotic lesions healed more rapidly but relapsed at 6 months more frequently than non-hyperkeratotic ones (32.9% versus 20.7%). The results showed gender-related differences: male patients recovered better and independently from the treatment used; in contrast, men showed a higher recurrence (32% at 6 months and 6.6% between 6 and 12 months versus 16% at 6 months and 5.9% between 6 and 12 months for females) and a higher average number of new lesions after 12 months from remission (1.6 versus 0.88 for females). Conclusion. The results may suggest a lower adherence to photoprotection in male patients. Hyperkeratotic lesions recurred mostly at 6 months in comparison to non-hyperkeratotic lesions.

Original languageEnglish
Pages (from-to)199-204
Number of pages6
JournalGiornale Italiano di Dermatologia e Venereologia
Volume149
Issue number2
Publication statusPublished - 2014

Fingerprint

Actinic Keratosis
Multicenter Studies
Prospective Studies
imiquimod
Cryotherapy
Curettage
Diclofenac
Skin Neoplasms
Hyaluronic Acid
Dermatology
Skin Diseases
Recurrence
Neoplasms

Keywords

  • Actinic
  • Gender
  • Keratosis
  • Recurrence

ASJC Scopus subject areas

  • Dermatology

Cite this

Relapsed actinic keratosis evaluation : An observational Italian multicenter prospective study. Does gender have a role? / Javor, S.; Chimenti, S.; Patrizi, A.; Stingeni, L.; Pellacani, G.; Cavicchini, S.; Sala, R.; Rongioletti, F.; Parodi, A.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 149, No. 2, 2014, p. 199-204.

Research output: Contribution to journalArticle

Javor, S, Chimenti, S, Patrizi, A, Stingeni, L, Pellacani, G, Cavicchini, S, Sala, R, Rongioletti, F & Parodi, A 2014, 'Relapsed actinic keratosis evaluation: An observational Italian multicenter prospective study. Does gender have a role?', Giornale Italiano di Dermatologia e Venereologia, vol. 149, no. 2, pp. 199-204.
Javor, S. ; Chimenti, S. ; Patrizi, A. ; Stingeni, L. ; Pellacani, G. ; Cavicchini, S. ; Sala, R. ; Rongioletti, F. ; Parodi, A. / Relapsed actinic keratosis evaluation : An observational Italian multicenter prospective study. Does gender have a role?. In: Giornale Italiano di Dermatologia e Venereologia. 2014 ; Vol. 149, No. 2. pp. 199-204.
@article{9ecd8b957df243fa88a615df0f1c0a8c,
title = "Relapsed actinic keratosis evaluation: An observational Italian multicenter prospective study. Does gender have a role?",
abstract = "Aim. Relapsed actinic keratoses evaluation study (RAKE) was performed in nine Italian centers of dermatology in order to observe the outcome of the treatments of these common skin neoplasms. Methods. A total of 182 patients were enrolled in 2 cohorts: the first included 144/182 patients (79.1{\%}) evaluated after 6 months from clinical remission, and the second 116/182 (63.7{\%}) evaluated for at least 12 months after clinical remission. Patients were previously treated with topical diclofenac 3{\%} in hyaluronic acid, cryotherapy, photodynamic, curettage or imiquimod cream. Results. Subjects with history of malignant skin diseases showed an increased number of new lesions at 16 months from baseline (12 months from remission) compared to patients without history of cancers (mean 1.58 versus 1.17). Hyperkeratotic lesions healed more rapidly but relapsed at 6 months more frequently than non-hyperkeratotic ones (32.9{\%} versus 20.7{\%}). The results showed gender-related differences: male patients recovered better and independently from the treatment used; in contrast, men showed a higher recurrence (32{\%} at 6 months and 6.6{\%} between 6 and 12 months versus 16{\%} at 6 months and 5.9{\%} between 6 and 12 months for females) and a higher average number of new lesions after 12 months from remission (1.6 versus 0.88 for females). Conclusion. The results may suggest a lower adherence to photoprotection in male patients. Hyperkeratotic lesions recurred mostly at 6 months in comparison to non-hyperkeratotic lesions.",
keywords = "Actinic, Gender, Keratosis, Recurrence",
author = "S. Javor and S. Chimenti and A. Patrizi and L. Stingeni and G. Pellacani and S. Cavicchini and R. Sala and F. Rongioletti and A. Parodi",
year = "2014",
language = "English",
volume = "149",
pages = "199--204",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Relapsed actinic keratosis evaluation

T2 - An observational Italian multicenter prospective study. Does gender have a role?

AU - Javor, S.

AU - Chimenti, S.

AU - Patrizi, A.

AU - Stingeni, L.

AU - Pellacani, G.

AU - Cavicchini, S.

AU - Sala, R.

AU - Rongioletti, F.

AU - Parodi, A.

PY - 2014

Y1 - 2014

N2 - Aim. Relapsed actinic keratoses evaluation study (RAKE) was performed in nine Italian centers of dermatology in order to observe the outcome of the treatments of these common skin neoplasms. Methods. A total of 182 patients were enrolled in 2 cohorts: the first included 144/182 patients (79.1%) evaluated after 6 months from clinical remission, and the second 116/182 (63.7%) evaluated for at least 12 months after clinical remission. Patients were previously treated with topical diclofenac 3% in hyaluronic acid, cryotherapy, photodynamic, curettage or imiquimod cream. Results. Subjects with history of malignant skin diseases showed an increased number of new lesions at 16 months from baseline (12 months from remission) compared to patients without history of cancers (mean 1.58 versus 1.17). Hyperkeratotic lesions healed more rapidly but relapsed at 6 months more frequently than non-hyperkeratotic ones (32.9% versus 20.7%). The results showed gender-related differences: male patients recovered better and independently from the treatment used; in contrast, men showed a higher recurrence (32% at 6 months and 6.6% between 6 and 12 months versus 16% at 6 months and 5.9% between 6 and 12 months for females) and a higher average number of new lesions after 12 months from remission (1.6 versus 0.88 for females). Conclusion. The results may suggest a lower adherence to photoprotection in male patients. Hyperkeratotic lesions recurred mostly at 6 months in comparison to non-hyperkeratotic lesions.

AB - Aim. Relapsed actinic keratoses evaluation study (RAKE) was performed in nine Italian centers of dermatology in order to observe the outcome of the treatments of these common skin neoplasms. Methods. A total of 182 patients were enrolled in 2 cohorts: the first included 144/182 patients (79.1%) evaluated after 6 months from clinical remission, and the second 116/182 (63.7%) evaluated for at least 12 months after clinical remission. Patients were previously treated with topical diclofenac 3% in hyaluronic acid, cryotherapy, photodynamic, curettage or imiquimod cream. Results. Subjects with history of malignant skin diseases showed an increased number of new lesions at 16 months from baseline (12 months from remission) compared to patients without history of cancers (mean 1.58 versus 1.17). Hyperkeratotic lesions healed more rapidly but relapsed at 6 months more frequently than non-hyperkeratotic ones (32.9% versus 20.7%). The results showed gender-related differences: male patients recovered better and independently from the treatment used; in contrast, men showed a higher recurrence (32% at 6 months and 6.6% between 6 and 12 months versus 16% at 6 months and 5.9% between 6 and 12 months for females) and a higher average number of new lesions after 12 months from remission (1.6 versus 0.88 for females). Conclusion. The results may suggest a lower adherence to photoprotection in male patients. Hyperkeratotic lesions recurred mostly at 6 months in comparison to non-hyperkeratotic lesions.

KW - Actinic

KW - Gender

KW - Keratosis

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84903181965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903181965&partnerID=8YFLogxK

M3 - Article

VL - 149

SP - 199

EP - 204

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 2

ER -